The Bulletin
Times Advertising


.

Immuno Cure Completed US$12M First Close of Series A Financing, led by AEF GBA Fund managed by Gobi Partners GBA

  • Written by The Bulletin

Advancing DNA vaccines & Immunotherapies for HIV, Cancers & Infectious Diseases

HONG KONG SAR - Media OutReach - 27 July 2023 - Immuno Cure BioTech ("Immuno Cure") is pleased to announce today that it has closed the US$12 million tranche in the US$27 million Series A fundraising round.

Read more: Immuno Cure Completed US$12M First Close of Series A Financing, led by AEF GBA Fund managed by...